Healthcare's Executive Suite Reshuffles as Layoffs Hit IT and Manufacturing Roles

Healthcare's labor market is sending two different signals at once. At the top, organizations are aggressively recruiting for AI, value-based care and product leadership. Further down the org chart, entire departments are getting consolidated or eliminated. The pattern is worth watching closely, because it points to where healthcare dollars are actually flowing this year.

Start with the hiring side. Adonis, an AI startup focused on hospitals' denied and underpaid claims, brought in Alison Bloom-Kiefer as chief product officer. She arrives from Oscar Health, where she led provider experience strategy and innovation. The company also promoted Doug Pickett to chief revenue officer. Pickett joined Adonis in 2023 as director of strategic sales after a stint at Cedar as vice president of commercial strategy. Two hires, one theme: claims automation is attracting serious executive talent.

Cone Health in North Carolina named Ryan Christensen as chief value-based care officer, poaching him from Intermountain Health, where he served as enterprise vice president of operations for proactive care services. Humana welcomed J.P. Holland as its new Medicaid president. Holland previously ran Johns Hopkins Health Plans as CEO and, before that, led Elevance Health's Alliance Business. Mayo Clinic tapped Arun Kumar Bhaskara-Baba as its new CIO, pulling him from Honeywell Aerospace and Defense, where he held the identical title. That's a notable cross-industry move, aerospace-to-hospital, worth flagging for anyone tracking how tech talent circulates.

Merck added Bart Gourley as chief AI officer. His resume includes leadership roles at EY, Amazon and Accenture, a combination that signals how seriously pharma is now treating AI governance at the executive level. Providence named Kevin Smith as its new CFO, effective October, after he departs SSM Health in the same role. And Quantum Health, the care navigation company, hired Jamie Hall as chief commercial officer and Daniel Stein as chief strategy officer. Both arrived through acquisitions: Hall via Quantum's purchase of CirrusMD, Stein via its purchase of Embold Health. Deal-driven hiring like this often signals integration challenges ahead.

Departures and Downsizing

Not every move this month was a hire. Centene CFO Drew Asher announced his retirement, effective at year-end, after holding the role since 2021. That's a long tenure by insurance-sector standards, and his exit will draw scrutiny given Centene's ongoing margin pressures in Medicaid managed care.

Tufts Medicine saw two of its top leaders step down simultaneously. CEO Mike Dandorph and CFO Andrew Devoe are both departing as the health system begins what it calls a major financial turnaround effort. Losing a CEO and CFO in tandem, during a turnaround, is a red flag worth watching. Leadership continuity matters most precisely when an organization needs stability to execute a financial recovery plan.

Then there are the layoffs, and they cluster in a telling pattern: manufacturing, IT and analytics.

Cellares, a cell therapy manufacturing specialist, plans to cut roughly 100 employees after Bristol Myers Squibb terminated its manufacturing partnership. That deal had positioned Cellares to produce the CAR-T therapy Breyanzi. The impacted workers are primarily software engineers, quality control staff and manufacturing specialists, exactly the roles you'd expect to shrink when a single anchor contract disappears. Concentration risk in biomanufacturing partnerships is not new, but this is a clean example of how quickly headcount can move when one buyer walks away.

MaineHealth is cutting 83 positions across its information technology and analytics departments. The health system is consolidating three teams into one as part of a broader redesign, eliminating 56 IT roles and 27 of its 63 analytics positions. Losing nearly half of an analytics function is a significant structural change, not a routine trim. It suggests MaineHealth is betting on automation or outsourcing to backfill capability, though the source material doesn't specify which.

Sharp HealthCare in San Diego announced a restructuring affecting 260 employees. This marks the system's second layoff wave in just over a year, following last summer's elimination of 315 roles. Sharp reported an operating loss of $173.5 million on $5.5 billion in revenue, and it cited rising costs alongside federal and state policy changes as drivers. Many affected workers were offered alternative positions within the system, a detail that softens the blow but doesn't erase the underlying financial strain. A health system posting a nine-figure operating loss on $5.5 billion in revenue is operating on thin margins, and repeat layoffs within thirteen months suggest the first round didn't solve the problem.

The Bottom Line

The split screen here is instructive. Executive hiring is concentrated in AI, value-based care and product leadership, areas where healthcare organizations believe they can generate revenue or efficiency gains. Layoffs are concentrated in IT, analytics and manufacturing support, the operational layers getting squeezed to fund those bets or absorb margin pressure. Sharp HealthCare's back-to-back layoffs and Tufts Medicine's dual C-suite exit during a turnaround are the two data points worth tracking most closely. Both suggest that financial stress in parts of the sector hasn't stabilized, even as capital keeps chasing AI and value-based care talent at the top.